secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRUKER CORP (BRKR)
CIK:        0001109354
Form:       8-K
Filed at:   2026-04-10T23:59:59+00:00
Accession:  0001193125-26-151220
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Bruker BioSpin President Falko Busse to depart; separation includes ~$1M severance
--------------------------------------------------------------------------------

- Falko Busse, Ph.D., to step down as President of Bruker BioSpin; duties transition May 1, 2026, employment ends Oct 31, 2026.
- Separation agreement provides approximately $1,020,351 in severance, prorated bonus, and unused vacation payout.
- Unvested equity awards as of Oct 31, 2026 will be forfeited per plan provisions.
- Agreement includes non-compete, non-solicitation, non-disparagement, and confidentiality covenants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1109354/000119312526151220/0001193125-26-151220-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1109354/000119312526151220/brkr-20260410.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-151220

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer